Does insurance cover Ozempic?

Most insurance plans cover Ozempic when it’s prescribed for type 2 diabetes, usually after a prior authorization confirms the diagnosis. Very few cover it for weight loss, which is an off-label use, and Medicare and Medicaid draw the same line.

What you pay with coverage depends on your plan’s drug tier and deductible. With a commercial plan, Novo Nordisk’s savings offer can bring Ozempic to as little as $25 a month (NovoCare).

What Ozempic is approved for

Ozempic carries a boxed warning: in rodents, semaglutide causes thyroid C-cell tumors, and Ozempic isn’t for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Its label, revised May 2026, lists three uses, all in adults with type 2 diabetes:

• Improving blood sugar control alongside diet and exercise
• Lowering the risk of heart attack, stroke and cardiovascular death in people with established heart disease
• Lowering the risk of kidney function decline, kidney failure and cardiovascular death in people with chronic kidney disease

Ozempic also comes as a daily tablet, and its label is for type 2 diabetes too. Weight loss isn’t on either label, so a prescription for weight loss alone is off-label. The semaglutide approved for weight management is Wegovy, at higher doses.

That’s why your diagnosis drives coverage. A plan that pays for diabetes care will usually cover Ozempic; a plan that covers weight loss will usually point you to Wegovy or Zepbound.

Ozempic coverage at a glance

Commercial insurance: diabetes yes, weight loss rarely

Commercial plans usually ask your clinician to confirm type 2 diabetes before they pay. Cigna’s policy for individual and family plans, effective June 15, 2026, approves Ozempic for 1 year with a documented type 2 diabetes diagnosis and lists weight-loss treatment under conditions not covered.

Even plans that have dropped weight-loss drugs keep paying for diabetes. Blue Cross Blue Shield of Massachusetts excluded Wegovy, Saxenda and Zepbound at renewals starting January 1, 2026, but said diabetes GLP-1s such as Ozempic and Mounjaro would stay covered with prior authorization, “including a documented diagnosis of type 2 diabetes” (FAQ).

How to check your Ozempic coverage

Call the member number on your card, or search your plan’s drug list online, and ask:

• Is Ozempic on the list, and on which drug tier?
• Does it need prior authorization, and what records does the plan want?
• Does the plan want you to try a different diabetes drug first?
• What will a month cost before and after your deductible?

Prior authorization means your plan wants records from your clinician, such as your diagnosis and lab results, before it pays. If it denies a prior authorization request, your insurer must explain why in writing within 15 days (HealthCare.gov), and that reason tells you whether a resubmission or an appeal makes sense.

If you don’t have diabetes and want semaglutide for weight loss, ask your plan about Wegovy instead. Our guide to Wegovy coverage covers the criteria by insurer, and Zepbound coverage covers the tirzepatide option.

Ozempic cost with insurance

With coverage, you pay your plan’s copay or coinsurance for Ozempic’s drug tier once you’ve met any deductible. Three things can lower it:

• Novo Nordisk’s savings offer. With commercial coverage, NovoCare says you can “pay as little as $25 per month for up to 3 months,” with savings capped at $100 a month. People with Medicare, Medicaid, TRICARE or other government coverage can’t use it (NovoCare).
• Express Scripts’ Patient Assurance Program. In July 2025, Express Scripts said Ozempic and Rybelsus would return to the program, which caps copays at $25 for up to a 34-day supply when your employer or plan takes part (Evernorth).
• Medicare’s caps. In 2026, no Part D plan can have a deductible over $615. After it, you pay 25% coinsurance until your spending on covered drugs reaches $2,100, then nothing more for the rest of the year. For 2027 those limits rise to $700 and $2,400 (Medicare.gov).

Without coverage, NovoCare’s self-pay price for the pen is $199 a month for the first 2 months at 0.25 mg and 0.5 mg for new patients, through December 31, 2026. After that it’s $349 a month for 0.25 mg, 0.5 mg or 1 mg and $499 for 2 mg. The tablet starts at $149 a month for 1.5 mg (NovoCare). Our Ozempic cost guide compares every route, and Ozempic coupons covers the savings offers.

Does Medicare cover Ozempic?

Yes, for type 2 diabetes, through Part D plans. Ozempic is part of Medicare’s drug price negotiation: CMS lists semaglutide (Ozempic, Rybelsus and Wegovy) as used by about 2.28 million Part D enrollees in 2024, and its negotiated price of $274 for a 30-day supply takes effect January 1, 2027, against a 2024 list price of $959 (CMS).

For weight loss, CMS says Medicare “generally” doesn’t cover GLP-1s (CMS). The exception is the Medicare GLP-1 Bridge, which runs from July 1, 2026, to December 31, 2027, at a $50 monthly copay. Its prior authorization form lists Foundayo, Wegovy injection, Wegovy tablets, Wegovy HD and the Zepbound KwikPen, not Ozempic, and sends type 2 diabetes requests to your regular Part D plan. Our Medicare guide explains who qualifies.

Medicaid and TRICARE

Medicaid must cover GLP-1s approved for diabetes, while covering them for obesity is a state option (KFF). So Ozempic for type 2 diabetes is covered, usually with prior authorization, but states that cover weight loss use drugs approved for it. See Medicaid GLP-1 coverage by state.

TRICARE covers Ozempic, Mounjaro, Trulicity and Victoza for type 2 diabetes if you meet its clinical criteria and your provider files prior authorization and medical necessity forms. TRICARE notes that Trulicity has a lower copayment (TRICARE FAQ). Coverage depends on the condition the drug treats, so Ozempic for weight loss isn’t covered (TRICARE). Our TRICARE guide covers the weight-loss rules by plan.

If your plan won’t cover Ozempic

If you have type 2 diabetes:

1. Ask which GLP-1 your plan prefers. Some plans favor a different drug in the same class at a lower copay.
2. Ask your clinician to resubmit with your diagnosis, A1C history and the diabetes medicines you’ve tried.
3. File an internal appeal within 180 days of the denial, then an external review if needed (HealthCare.gov).

If you want it for weight loss: ask whether your plan covers Wegovy, Zepbound or Foundayo for weight management, which have their own criteria. On Medicare, the $50 Bridge is the route. Otherwise, self-pay applies: brand-name pills start at $149 a month, and our guide to GLP-1s without insurance lists every cash option.

Online compounded programs cost less. At the 26 programs we rank, as of November 2026, compounded semaglutide costs $65 to $299 a month at each program’s lowest ongoing price, medication included. Compounded semaglutide is not Ozempic and not a generic of it. A compounding pharmacy prepares it, and it isn’t FDA-approved or reviewed by the FDA for safety, effectiveness or quality (FDA). Read our compounded GLP-1 guide before choosing that route, or compare brand-name options on GLP-1 programs that help with insurance.

The bottom line

Insurance covers Ozempic for what it’s approved to treat: type 2 diabetes and the heart and kidney risks that come with it. For weight loss, ask about Wegovy, Zepbound or Foundayo coverage instead, and check the Medicare Bridge if you’re on Part D. Talk with a licensed clinician about which drug fits your health before you file.